Basic Information
RELIGN, a startup located in the heart of Silicon Valley, is committed to innovation in the field of arthroscopy, providing surgeons with top-tier products for more effective treatment outcomes. As pioneers in the arthroscopy space, we are dedicated to the complete advancement of resection technology. Drawing on years of experience, cutting-edge R&D, and surgeon feedback, RELIGN has launched the Tricera™ system. Tricera is a revolutionary, advanced system that integrates ablation/coagulation, tissue resection, bone cutting, and fluid management into one unique platform. RELIGN continues to emphasize R&D, focusing on delivering high-quality, effective solutions to further advance arthroscopic surgery.
ReLign Corporation
California,United States of America
15~50 people
January 01, 2011
info@religncorp.com

